R & d- medical: biomedical (basic research)

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201500034C
Awardee
Awarding agency
Obligated
$299,356

Award facts

Contract value 100% obligated
$299,356.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 27 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Brookline, MA 02445, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $299,356

About this award

This is a $299,356.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Entropia Biosciences Inc., a self-certified small disadvantaged business. The contract is for research and development in the biomedical field, specifically for a SBIR Program Phase I action. The contract has a set-aside designation for total small business. The award date was September 22, 2015, and the ultimate completion date is June 21, 2016.

Quick answers

Who was awarded contract HHSN261201500034C?

HHSN261201500034C was awarded to Entropia Biosciences Inc. by National Cancer Institute (National Institutes of Health) on September 22, 2015.

How much is contract HHSN261201500034C worth?

The government has obligated $299,356 on HHSN261201500034C.

Was contract HHSN261201500034C competed?

The extent of competition for HHSN261201500034C was full and open competition after exclusion of sources. The government received 27 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award